Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia
Anna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, Roberto Cairoli, Marco MontilloDepartment of Hematology, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy Abstract: Treatment aim for chronic lymphocytic leukemia has been radically changed over the past years from p...
Enregistré dans:
Auteurs principaux: | Frustaci AM, Tedeschi A, Picardi P, Cairoli R, Montillo M |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/338dbfaba9a843b1932eb2d55b9de2cb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
par: Marco Montillo, et autres
Publié: (2008) -
Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
par: Cerquozzi S, et autres
Publié: (2015) -
Chronic lymphocytic leukemia in general practice
par: Đurović Ljiljana P.
Publié: (2021) -
Chronic lymphocytic leukemia/small lymphocytic lymphoma
par: E. A. Nikitin, et autres
Publié: (2020) - Lymphoma & Chronic Lymphocytic Leukemias